Frog-Inspired Brain-Like Sensor: A World First

Indian scientists have developed a humidity-responsive neuromorphic sensor inspired by frog biology that can sense, process, and store information simultaneously within a single device — mimicking how the human brain works. The research, announced in early April 2026, represents a major leap in neuromorphic electronics, a field that seeks to build computing systems modelled on biological neural networks rather than traditional silicon architectures.

The sensor is based on the remarkable ability of frogs to detect humidity changes through their skin. Researchers replicated this biological mechanism using specially engineered materials that change their electrical properties in response to moisture, while simultaneously acting as both processor and memory. Traditional electronics require separate components for sensing, computing, and storage; this device combines all three into one — potentially reducing energy consumption by orders of magnitude.

The implications are far-reaching. If scaled, neuromorphic sensors could transform fields from wearable health devices (detecting sweat composition in real time) to environmental monitoring (smart sensors in agriculture that respond autonomously to humidity changes). The research also feeds into India’s growing AI hardware ecosystem, where the convergence of biology and computation is creating new categories of intelligent devices.

India Launches First Indigenous CAR-T Cancer Therapy

In what may be the most consequential medical development from India this year, NexCAR19 — India’s first indigenous CAR-T (Chimeric Antigen Receptor T-cell) cell therapy — was launched in early April 2026 for treating leukemia and lymphoma. CAR-T therapy works by extracting a patient’s T-cells (a type of immune cell), genetically engineering them to recognise and attack cancer cells, and infusing them back into the patient. Until now, CAR-T treatments were only available from Western pharmaceutical companies at costs exceeding ₹3–4 crore per patient, putting them out of reach for virtually all Indian cancer patients.

NexCAR19, developed by ImmunoACT — a company spun out of the Indian Institute of Technology Bombay in collaboration with Tata Memorial Hospital — aims to deliver the therapy at a fraction of the international cost: initial estimates place the price at ₹30–40 lakh, still significant but transformative for a country where an estimated 15 lakh new cancer cases are diagnosed annually. Early clinical trials showed promising results in B-cell acute lymphoblastic leukemia (B-ALL), with high complete-remission rates.

This development is part of a broader trend in Indian healthcare innovation, paralleling breakthroughs in healthtech startups like Temple that are leveraging technology to reduce the cost of advanced medical care.

How Bacteria Share Antibiotic Resistance: A Startling Discovery

In a research paper published on April 16, 2026, an international team of scientists revealed a surprising new mechanism by which bacteria share antibiotic-resistance genes — through “selfless” DNA transfer mediated by Gene Transfer Agents (GTAs). Unlike traditional horizontal gene transfer, where bacteria exchange genetic material through conjugation or transformation, GTAs are tiny virus-like particles that a bacterium produces at the cost of its own survival: the host cell essentially explodes to release GTAs carrying DNA fragments, which are then taken up by neighbouring bacteria.

This discovery has profound implications for the global fight against antimicrobial resistance (AMR), which the WHO considers one of the top ten public health threats. If bacteria can spread resistance genes through self-sacrifice — a form of biological altruism — then the spread of AMR may be even more rapid and pervasive than previously modelled. The findings suggest that new strategies targeting GTAs, rather than just the bacteria themselves, may be needed to contain the resistance crisis.

CRISPR Centre of Excellence at JNCASR Bengaluru

India’s Department of Science and Technology signed a Letter of Intent to establish a Centre of Excellence for CRISPR Innovation and Translation (CoE-CIT) at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bengaluru, in partnership with CrisprBits, a Delhi-based biotechnology firm. The centre aims to translate cutting-edge CRISPR gene-editing discoveries from the laboratory into real-world clinical applications.

CRISPR technology — which allows scientists to edit DNA with unprecedented precision — has transformed biology globally since its invention in 2012. India, however, has lagged behind the US, China, and Europe in applying CRISPR to agriculture, medicine, and industrial biotechnology. CoE-CIT is designed to close this gap by providing shared infrastructure, regulatory guidance, and translational research support to academic labs and startups.

The centre’s initial focus will include CRISPR-based diagnostics for tropical diseases, gene therapies for sickle-cell anemia (which disproportionately affects Indian tribal populations), and agricultural applications such as drought-resistant crop varieties that could bolster India’s food security under changing climate conditions.

India’s Biotech Sector: The Bigger Picture

These four developments — neuromorphic bio-sensors, CAR-T therapy, GTA-mediated resistance, and CRISPR infrastructure — are not isolated events. They reflect a maturing Indian biotech ecosystem that is attracting both talent and capital. The Indian biotech sector was valued at approximately $130 billion in 2025 and is projected to reach $200 billion by 2030, driven by pharmaceutical exports, contract research, and a growing domestic demand for advanced healthcare.

Government investment through the Biotechnology Industry Research Assistance Council (BIRAC) and private-sector funding from venture capital firms are creating a pipeline of startups focused on synthetic biology, precision medicine, and agricultural biotech. India’s Science & Space sector is increasingly intertwined with its biotech ambitions, as satellite data for crop monitoring, AI for drug discovery, and quantum computing for protein folding begin to converge.

What’s at Stake

For India, the biotech revolution is not just about economic opportunity — it is about equity. NexCAR19’s mission to make cancer therapy affordable, CoE-CIT’s focus on tribal healthcare, and neuromorphic sensors’ potential to democratise smart agriculture all address the fundamental challenge of ensuring that scientific progress reaches the 800 million Indians who live on less than $5 a day. April 2026 is a reminder that India’s most transformative innovations may come not from Silicon Valley but from the intersection of biology and necessity.

Explore more on Biology at Daily Tips for cutting-edge science and research updates from India and the world.

The post From Frog-Inspired Brain Sensors to India’s First CAR-T Therapy: Biotech Breakthroughs Redefining Indian Science in 2026 appeared first on Daily Tips.

India Research Output ANRF 2026: The Foundation Takes Shape

The Anusandhan National Research Foundation, established by an Act of Parliament in 2023 with a mandate to seed, grow and promote research across India, has moved from planning to execution. With an initial budget of Rs 50,000 crore over five years — supplemented by private sector contributions — the ANRF represents a tenfold increase in competitive research funding compared to the agencies it subsumes, including elements of the Department of Science and Technology, the Council of Scientific and Industrial Research and the University Grants Commission’s research programmes.

The ANRF’s first round of grants, announced in December 2025, funded 2,400 projects across 14 thematic areas including artificial intelligence, clean energy, quantum computing, advanced materials, space technology and public health. The grants ranged from Rs 25 lakh for early-career researchers to Rs 15 crore for collaborative programmes involving multiple institutions. Notably, the ANRF has mandated that at least 30 per cent of grants must go to researchers at state universities and emerging institutions, addressing a long-standing concentration of research funding at elite institutions like the IITs and IISc.

This research expansion connects to India’s broader scientific ambitions, including the ISRO and AIIMS space medicine partnership that demonstrates the country’s commitment to pushing the boundaries of applied science. The ANRF’s emphasis on translational research — converting laboratory discoveries into products, policies and public benefits — distinguishes it from traditional academic funding models.

Publication Numbers Tell Only Part of the Story

India published approximately 320,000 research papers in international journals in 2025, a 15 per cent increase from 2023 and more than double the output from a decade earlier. The country’s share of global scientific publications has risen to 8.5 per cent, placing it firmly in third position. However, quantity alone does not capture research quality, and this is where the picture becomes more nuanced.

India’s average citation impact — a measure of how frequently published research is referenced by other scientists — has improved but still lags behind the global average. While the top tier of Indian research, particularly in chemistry, materials science, pharmacology and computer science, is genuinely world-class, a significant volume of publications appear in lower-impact journals and receive minimal citations. The ANRF has explicitly addressed this by tying funding renewals to quality metrics rather than pure publication counts, encouraging researchers to prioritise significant contributions over volume.

Patent filings, another indicator of research relevance, have shown encouraging growth. Indian patent filings at the Indian Patent Office crossed 90,000 in 2025, with a growing proportion originating from academic institutions rather than corporations. The Council of Scientific and Industrial Research’s (CSIR) laboratories alone filed over 1,200 patents, reflecting an institutional shift towards commercially applicable research.

Key Research Breakthroughs of 2025-26

Several Indian research achievements in the past year have attracted international attention. Researchers at IISc Bengaluru developed a novel solid-state battery electrolyte using abundantly available materials, a breakthrough that could reduce India’s dependence on imported lithium for electric vehicle batteries. The work, published in Nature Energy, was described by peer reviewers as one of the most significant advances in solid-state battery technology in recent years.

In biotechnology, the Indian Institute of Chemical Technology in Hyderabad developed a low-cost diagnostic platform for detecting multiple infectious diseases simultaneously using a single blood sample. The technology, which uses microfluidic chips manufactured in India, has potential applications across the developing world where access to sophisticated laboratory equipment is limited.

Space research continues to be a source of national pride. ISRO’s analysis of data from the Chandrayaan-3 lunar mission has produced over 40 peer-reviewed papers on lunar soil composition, thermal properties and potential water ice deposits. The climate change research reshaping Indian wildlife studies has also produced significant findings, with Indian ecologists contributing important data on how rising temperatures are affecting biodiversity in tropical and Himalayan ecosystems.

The Private Sector Steps In

One of the ANRF’s distinctive features is its mandate to mobilise private sector investment in research. India’s private sector research and development spending, at approximately 0.35 per cent of GDP, is significantly lower than in China (1.3 per cent), South Korea (2.5 per cent) and the United States (2 per cent). The ANRF is designed to change this through matching grants, tax incentives and collaborative platforms that connect corporate R&D teams with academic researchers.

Early results are promising. Tata Group has committed Rs 1,000 crore to ANRF-aligned research in materials science and AI. Reliance Industries has established a quantum computing research lab in partnership with IIT Bombay, funded jointly by the company and the ANRF. Infosys Foundation has directed Rs 500 crore towards AI research grants through the ANRF framework. These partnerships represent a cultural shift in India’s innovation ecosystem, where academic research and corporate R&D have historically operated in isolation.

The particle physics breakthrough at CERN in 2026 demonstrates how fundamental research connects to India’s broader technological ambitions, with the line between academic discovery and technological application becoming increasingly blurred.

Challenges: Brain Drain, Bureaucracy and Infrastructure

Despite progress, India’s research ecosystem faces persistent structural challenges. The brain drain of talented researchers to universities and companies in the United States, United Kingdom and Europe continues, driven by higher salaries, better-equipped laboratories and more supportive research environments. The ANRF aims to address this through competitive international-standard salaries for ANRF-funded researchers and returning scientist fellowship programmes, but reversing decades of talent outflow will take time.

Bureaucratic procurement processes remain a frustration for Indian researchers. Purchasing laboratory equipment and consumables involves multi-layered approvals that can delay research by months. ANRF grants include provisions for streamlined procurement, but the broader institutional culture of risk-averse bureaucratic approval persists at many universities.

Research infrastructure, while improving, remains inadequate outside the top-tier institutions. State universities, which educate the majority of India’s students, often lack basic laboratory facilities, library subscriptions and computing resources necessary for competitive research. The ANRF’s allocation for state universities is a positive step, but the scale of investment required to bring hundreds of institutions to research-capable standards is enormous.

India’s Research Ambitions: The Next Decade

India’s research trajectory in 2026 is unmistakably upward. The ANRF provides a funding and governance framework that, if implemented effectively, can transform India from a high-volume but inconsistent research producer into a nation that regularly generates breakthrough science with global impact. The talent exists, the funding is growing, and the political will is evident. The challenge is execution — ensuring that increased spending translates into genuine research excellence rather than administrative expansion. India’s position as the third-largest research producer in the world is a starting point, not a destination.

The post India’s Research Output Hits Record High as Anusandhan National Research Foundation Begins Funding in 2026 appeared first on Daily Tips.